English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 36 Help

Selected(0)Clear Items/Page:    Sort:
Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction Journal article
Food Frontiers, 2022
Authors:  Li Yang;  Yongchao Gao;  Jupeng Gong;  Hui Wang;  MohamedA. Farag;  JesusSimal-Gandara;  Yonghua Zhao;  Shaoping Nie;  Jianbo Xiao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/07/31
Fecal Microbiota Transplantation  Immunomodulatory  Intestinal Microbiota  Myricetin  Predia-betes  
Using flavonoids as a therapeutic intervention against rheumatoid arthritis: The known and unknown Journal article
Pharmacological Research - Modern Chinese Medicine, 2022,Volume: 3,Issue: 2022
Authors:  Zhimin Miao;  Yuxin Zhao;  Meiwan Chen;  Chengwei He
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/07/29
Rheumatoid Arthritis  Flavonoids  Immunoregulation  Gut-joint Axis  Inflammatory Responses  
Herbal composition JCM-16021 as treatment for inflammatory bowel disease Patent
专利类型: 实用新型Utility model,
Authors:  Wang Y(王穎);  Wang YT(王一涛);  Bian ZX(卞兆祥)
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/08/12
Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas Journal article
Cancer Biology and Medicine, 2021,Volume: 18,Issue: 4,Page: 1010-1020
Authors:  Li, Ping;  Chen, Fengyang;  Zheng, Jingbin;  Yang, Yang;  Li, Yuan;  Wang, Yifei;  Chen, Xin
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date：2021/12/08
Bleomycin  Cyclophosphamide  Tnfr2  Tregs  Tumor Necrosis Factor  
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy Book chapter
出自: Cancer Immunotherapy:Elsevier, 2019, 页码: 101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite |  | TC[WOS]:12 TC[Scopus]:10 | Submit date：2019/05/08
TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science:ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2019, 页码: 101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite |  | TC[WOS]:12 TC[Scopus]:10 | Submit date：2020/05/05
Regulatory t Cells  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy  Tumor Necrosis Factor  
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Other
2019-01-01
Authors:  He, J.;  Li, Ruixin;  Chen, Yibo;  Hu, Yuanjia;  Chen, Xin
Favorite |  | TC[WOS]:12 TC[Scopus]:10 | Submit date：2022/05/23
Cancer  Immunotherapy  Regulatory T cells  Tumor necrosis factor  Tumor necrosis factor receptor type 2  
The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  He, Tianzhen;  Liu, Shuoyang;  Chen, Shaokui;  Ye, Jingyi;  Wu, Xueqiang;  Bian, Zhaoxiang;  Chen, Xin
Favorite |  | TC[WOS]:24 TC[Scopus]:22 | Submit date：2018/10/30
tumor necrosis factor  TNF receptor type II  p38 MAPK  CD4(+)Foxp3(+) regulatory T cells  proliferation  
TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Shaikh, Faraz;  He, Jiang;  Bhadra, Pratiti;  Chen, Xin;  Siu, Shirley W., I
Favorite |  | TC[WOS]:11 TC[Scopus]:13 | Submit date：2018/10/30
Tnf Receptor Type Ii  Tnf  Regulatory t Cells  Virtual Screening  Drug Discovery  Mm-pbsa  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite |  | TC[WOS]:32 TC[Scopus]:30 | Submit date：2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy